Gonorrhea Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Gonorrhea Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Pharmaceutical

Report Description

Gonorrhea is caused due to bacterial infection (Neisseria gonorrhoeae) that can be passed from one person to another during sex. Gonorrhea is a sexually transmitted disease (STD) affecting both men and women globally. The gonorrhea bacteria infects cervix, uterus and urethra etc. mucous membranes, which are soft tissues and not covered by skin or outer layer. Changes in urination pattern, pain during sex, unusual discharges from male and female sex organs, bleeding, bumps, and sores, pain in the pelvic or abdominal region, and burning or itching in the vaginal area are some of the most common symptoms of gonorrhea. Long-term pelvic pain, infertility, ectopic pregnancy, proctitis, and prostate gland infection are major complications caused by gonorrhea. Nucleic acid amplification tests (NAAT), direct fluorescent tests, and several others tests are recommended by health care specialists to confirm the gonorrhea disease. According to WHO report, over 10 million people are diagnosed with gonorrhea globally each year. Generally, antibiotics and antibacterial medicines are used to treat gonorrhea.

The global gonorrhea drugs market is expanding significantly due to increasing gonorrhea prevalence. Rise in incidence of unprotected sex has led to an increase in the prevalence gonorrhea. Low voluntary screening rate for the disease is a major restrain of the market. Awareness about gonorrhea infection diagnostic tests is extremely low in countries in Africa. Hence, companies are facing challenges with regard to market penetration in the region. Moreover, several low- and middle-income countries depend on government grants for the provision of rapid diagnostic tests in the event of an epidemic. Therefore, direct reach to customers is weaker in these countries. These factors hamper the market in the region.

The global gonorrhea drugs market can be segmented based on drug type, distribution channel, and region. In terms of drug type, the market can be categorized into sulfonamides, tetracycline, aminopenicillins, and macrolides. Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea bacteria. Erythromycin, clarithromycin, azithromycin, and roxithromycin are the most recommended macrolides. In terms of revenue, the macrolides segment held a significant share of the gonorrhea drug market in 2016. Tetracycline is an antibiotic that fights infection caused by bacteria such as Neisseria gonorrheae and is the second major drug after macrolides.

In terms of distribution channel, the global gonorrhea drugs market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. Based on revenue, the hospital pharmacies segment held a significant share of the gonorrhea drugs market in 2016.

In terms of region, the global gonorrhea drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for gonorrhea drugs. In terms of revenue, the U.S. holds a major share of the gonorrhea drugs market in North America. The market in Europe is expanding rapidly due to an increase in the patient population, especially in the U.K. and Germany. The market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and Japan are anticipated to contribute to the growth of the market in Asia Pacific between 2017 and 2025 due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness.

Key players operating in the global gonorrhea drugs market are Pfizer, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Eli Lilly and Company, Glenmark Generics Ltd., Dr. Reddy's Laboratories Ltd., Mylan N.V., Hi-Tech Pharmacal Co., Inc., and Lupin Ltd., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market      

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients